Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (+)-prostaglandin A2
2. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid
3. (z)-7-((1r,2s)-2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic Acid
4. Medullin
5. Pga2
1. Medullin
2. Pga2
3. 13345-50-1
4. (+)-prostaglandin A2
5. 5,6-cis-pga2
6. (15s)-pga2
7. (+)-prostaglandin A(sup 2)
8. K6vt5bdy9e
9. 15(s)-prostaglandin A2
10. Chebi:27820
11. Prosta-5,10,13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
12. 9-oxo-15s-hydroxy-5z,10z,13e-prostatrienoic Acid
13. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic Acid
14. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic Acid
15. Nsc 165561
16. Pga2 (prostaglandin A2)
17. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostenoic Acid
18. Pga(sup 2)
19. Prosta-5,10,13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
20. 5,6-cis-pga(sup 2)
21. Mls000069589
22. Prostaglandin A(sup 2)
23. Unii-k6vt5bdy9e
24. (155)-pga2
25. Brn 2221844
26. Nsc-165561
27. (~{z})-7-[(1~{r},5~{s})-2-oxidanylidene-5-[(~{e},3~{s})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic Acid
28. Smr000058790
29. Pga2(prostaglandin A2)
30. Bspbio_001460
31. Bml1-f02
32. Gtpl6279
33. Schembl2115595
34. Chembl1084643
35. Dtxsid20864388
36. Prostaglandin A2 (pga2)
37. Hms1361i22
38. Hms1791i22
39. Hms1989i22
40. Hms3402i22
41. Hms3648i11
42. Zinc4521813
43. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid
44. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic Acid
45. Lmfa03010035
46. Prosta-5,10-13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
47. (z)-7-((1r,2s)-2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic Acid
48. 5-heptenoic Acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (van)
49. Idi1_033930
50. Ncgc00022061-03
51. Ncgc00022061-04
52. Ncgc00022061-05
53. Hy-113041
54. Cs-0059420
55. Dinoprostone Impurity D [ep Impurity]
56. C05953
57. Sr-01000946222
58. Sr-01000946222-1
59. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostenoate
60. Brd-k34782918-001-02-5
61. Q27088462
62. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate
63. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate
64. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid
65. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate
66. 362927f3-3a3e-47bc-84c3-c32a293aa956
67. 15.alpha.-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid
68. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic Acid
69. 15.alpha.-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic Acid
70. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]hept-5-enoic Acid
71. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]hept-5-enoic Acid
72. Dinoprostone Impurity, (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid- [usp Impurity]
| Molecular Weight | 334.4 g/mol |
|---|---|
| Molecular Formula | C20H30O4 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 12 |
| Exact Mass | 334.21440943 g/mol |
| Monoisotopic Mass | 334.21440943 g/mol |
| Topological Polar Surface Area | 74.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 476 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Prostaglandin A2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prostaglandin A2, including repackagers and relabelers. The FDA regulates Prostaglandin A2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prostaglandin A2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Prostaglandin A2 supplier is an individual or a company that provides Prostaglandin A2 active pharmaceutical ingredient (API) or Prostaglandin A2 finished formulations upon request. The Prostaglandin A2 suppliers may include Prostaglandin A2 API manufacturers, exporters, distributors and traders.
Prostaglandin A2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prostaglandin A2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prostaglandin A2 GMP manufacturer or Prostaglandin A2 GMP API supplier for your needs.
A Prostaglandin A2 CoA (Certificate of Analysis) is a formal document that attests to Prostaglandin A2's compliance with Prostaglandin A2 specifications and serves as a tool for batch-level quality control.
Prostaglandin A2 CoA mostly includes findings from lab analyses of a specific batch. For each Prostaglandin A2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prostaglandin A2 may be tested according to a variety of international standards, such as European Pharmacopoeia (Prostaglandin A2 EP), Prostaglandin A2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prostaglandin A2 USP).
LOOKING FOR A SUPPLIER?
